Tenet Healthcare (NYSE:THC) Shares Up 11.8% After Strong Earnings

Tenet Healthcare Corporation (NYSE:THCGet Free Report) rose 11.8% during trading on Wednesday following a stronger than expected earnings report. The stock traded as high as $216.04 and last traded at $215.90. Approximately 897,753 shares changed hands during trading, a decline of 4% from the average daily volume of 933,138 shares. The stock had previously closed at $193.04.

The company reported $4.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm’s quarterly revenue was up 8.9% on a year-over-year basis. During the same quarter last year, the company posted $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS.

Trending Headlines about Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

Analysts Set New Price Targets

Several equities analysts have recently weighed in on THC shares. Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, January 31st. Truist Financial reiterated a “buy” rating and set a $240.00 price target (up previously from $225.00) on shares of Tenet Healthcare in a research note on Monday, November 3rd. Guggenheim upped their price objective on Tenet Healthcare from $238.00 to $257.00 and gave the stock a “buy” rating in a research note on Tuesday, December 2nd. Barclays lifted their target price on Tenet Healthcare from $229.00 to $240.00 and gave the company an “overweight” rating in a research report on Friday, November 21st. Finally, KeyCorp raised their price objective on Tenet Healthcare from $225.00 to $250.00 and gave the stock an “overweight” rating in a research note on Thursday. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $241.00.

Read Our Latest Stock Report on THC

Insider Transactions at Tenet Healthcare

In related news, Director Nadja West sold 2,178 shares of the business’s stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the transaction, the director directly owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. The trade was a 7.10% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.81% of the company’s stock.

Institutional Trading of Tenet Healthcare

Hedge funds have recently modified their holdings of the company. Triumph Capital Management bought a new stake in Tenet Healthcare in the third quarter worth $25,000. Activest Wealth Management bought a new stake in shares of Tenet Healthcare in the 4th quarter worth about $26,000. Elyxium Wealth LLC bought a new position in shares of Tenet Healthcare in the 4th quarter valued at about $29,000. William B. Walkup & Associates Inc. purchased a new position in Tenet Healthcare in the third quarter worth about $32,000. Finally, Canada Pension Plan Investment Board purchased a new stake in Tenet Healthcare during the second quarter valued at approximately $35,000. 95.44% of the stock is owned by hedge funds and other institutional investors.

Tenet Healthcare Price Performance

The firm has a market capitalization of $20.44 billion, a P/E ratio of 15.01, a price-to-earnings-growth ratio of 0.95 and a beta of 1.44. The company has a current ratio of 1.76, a quick ratio of 1.64 and a debt-to-equity ratio of 2.18. The firm has a 50 day moving average price of $198.41 and a 200-day moving average price of $194.17.

About Tenet Healthcare

(Get Free Report)

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

Read More

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.